{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:45Z","timestamp":1786985085690,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117707","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:50:02Z","timestamp":1768409402000},"page":"117707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"246","author":[{"given":"Cristina Di","family":"Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Sensini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Lachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marchian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Paniconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa De","family":"Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Moraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Catalanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cartaginese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Biagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117707_b0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.117707_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","article-title":"Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches","volume":"14","author":"Orth","year":"2019","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.bcp.2026.117707_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.bcp.2026.117707_b0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.117707_b0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117707_b0030","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.7150\/thno.26546","article-title":"The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer","volume":"8","author":"Sun","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.117707_b0035","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.117707_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.117707_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.939969","article-title":"Next-generation sequencing analysis of gastric cancer identifies the leukemia inhibitory factor receptor as a driving factor in gastric cancer progression and as a predictor of poor prognosis","volume":"12","author":"Di Giorgio","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.117707_b0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2026.117707_b0055","first-page":"131","article-title":"Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF)","volume":"85","author":"Kamohara","year":"1994","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117707_b0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s42003-021-01928-2","article-title":"An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy","volume":"4","author":"Hunter","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2026.117707_b0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13402-023-00893-8","article-title":"The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer","volume":"47","author":"Di Giorgio","year":"2023","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bcp.2026.117707_b0070","doi-asserted-by":"crossref","first-page":"20403","DOI":"10.1038\/s41598-024-71014-0","article-title":"Impact of anti leukemia inhibitory factor antibody on immune related gene expression in breast cancer Balb\/c mouse model","volume":"14","author":"Seifati","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.117707_b0075","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.1021\/acs.jmedchem.5c00705","article-title":"Harnessing the estradienone scaffold to develop dual GPBAR1 and LIFR modulators for liver fibrosis","volume":"68","author":"De Gregorio","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117707_b0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bcp.2026.117707_b0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bcp.2026.117707_b0090","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2026.117707_b0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02614362","article-title":"A globally convergent version of the Polak-Ribi\u00e8re conjugate gradient method","volume":"78","author":"Grippo","year":"1997","journal-title":"Math. Program."},{"key":"10.1016\/j.bcp.2026.117707_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116134","article-title":"Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis","volume":"223","author":"Di Giorgio","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117707_b0105","doi-asserted-by":"crossref","first-page":"18334","DOI":"10.1021\/acs.jmedchem.4c01651","article-title":"Design, synthesis, and pharmacological evaluation of dual FXR-LIFR modulators for the treatment of liver fibrosis","volume":"67","author":"Rapacciuolo","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117707_b0110","unstructured":"2025 Schr\u00f6dinger Release 2025-1: Qm-Polarized Ligand Docking Protocol, Glide, Jaguar, Schr\u00f6dinger, LLC QSite, Schr\u00f6dinger; Schr\u00f6dinger, LLC: New York, NY, ., (n.d.)."},{"key":"10.1016\/j.bcp.2026.117707_b0115","unstructured":"2021. Schr\u00f6dinger Release 2023-1: Induced Fit Docking Protocol, Glide, Prime Schr\u00f6dinger, LLC; Schr\u00f6dinger, LLC: New York, NY, ., (n.d.)."},{"key":"10.1016\/j.bcp.2026.117707_b0120","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1535-7163.MCT-18-1258","article-title":"EC359: a first-in-class small-molecule inhibitor for targeting oncogenic LIFR signaling in triple-negative breast cancer","volume":"18","author":"Viswanadhapalli","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2026.117707_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-014-0110-2","article-title":"Biological roles of CCAAT\/enhancer-binding protein delta during inflammation","volume":"22","author":"Ko","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.117707_b0130","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.celrep.2017.08.039","article-title":"ALPK1- and TIFA-dependent innate immune response triggered by the Helicobacter pylori type IV secretion system","volume":"20","author":"Zimmermann","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.117707_b0135","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1158\/1541-7786.MCR-10-0565","article-title":"Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts","volume":"9","author":"Duan","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117707_b0140","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/OTT.S237162","article-title":"IFI30 is a novel immune-related target with predicting value of prognosis and treatment response in glioblastoma","volume":"13","author":"Zhu","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bcp.2026.117707_b0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-022-02300-w","article-title":"Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117707_b0150","first-page":"2528","article-title":"Identification of carboxypeptidase X (CPX)-1 as a positive regulator of adipogenesis","volume":"30","author":"Kim","year":"2016","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2026.117707_b0155","doi-asserted-by":"crossref","first-page":"14824","DOI":"10.1074\/jbc.M113.451336","article-title":"Transforming growth factor-\u03b21 (TGF-\u03b21)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts","volume":"288","author":"Midgley","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117707_b0160","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.117707_b0165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cvr\/cvt207","article-title":"Cysteine-rich protein 2 alters p130Cas localization and inhibits vascular smooth muscle cell migration","volume":"100","author":"Chen","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.117707_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1051497","article-title":"The role and mechanism of claudins in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.117707_b0175","doi-asserted-by":"crossref","first-page":"L190","DOI":"10.1152\/ajplung.00448.2003","article-title":"Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts","volume":"288","author":"Bogatkevich","year":"2005","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.bcp.2026.117707_b0180","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135296","article-title":"Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating \u03b2-catenin-dependent vascular remodeling","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.117707_b0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1165\/rcmb.2002-0243OC","article-title":"Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation","volume":"29","author":"Kolodsick","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2026.117707_b0190","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.3390\/cells11213482","article-title":"Repositioning mifepristone as a leukaemia inhibitory factor receptor antagonist for the treatment of pancreatic adenocarcinoma","volume":"11","author":"Di Giorgio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.117707_b0195","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1073\/pnas.0705577104","article-title":"An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor","volume":"104","author":"Huyton","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2026.117707_b0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bjc.2013.748","article-title":"Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction","volume":"110","author":"Nagasaki","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.117707_b0205","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-10-3142","article-title":"Altered TGF-\u03b2 signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis","volume":"71","author":"Franco","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.117707_b0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.117707_b0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.matbio.2016.08.001","article-title":"Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions","volume":"60\u201361","author":"Wang","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bcp.2026.117707_b0220","article-title":"Cancer-associated fibroblasts regulate the plasticity of breast cancer stemness through the production of Leukemia inhibitory factor","volume":"11","author":"Vaziri","year":"2021","journal-title":"Life (Basel, Switzerland)"},{"key":"10.1016\/j.bcp.2026.117707_b0225","first-page":"90","article-title":"Expression and significance of leukemia inhibitory factor in human pancreatic cancer","volume":"94","author":"Peng","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.bcp.2026.117707_b0230","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-019-10369-9","article-title":"LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy","volume":"10","author":"Pascual-Garc\u00eda","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117707_b0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121221","article-title":"Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin","volume":"3","author":"Arora","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.117707_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1140730","article-title":"Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma","volume":"13","author":"Di Giorgio","year":"2023","journal-title":"Front. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:35:37Z","timestamp":1778056537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S0006295226000389"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117707","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117707"}}